BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arcones AC, Vila-Bedmar R, Mirasierra M, Cruces-Sande M, Vallejo M, Jones B, Tomas A, Mayor F Jr, Murga C. GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo. BMC Biol 2021;19:40. [PMID: 33658023 DOI: 10.1186/s12915-021-00966-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Varney MJ, Steyaert W, Coucke PJ, Delanghe JR, Uehling DE, Joseph B, Marcellus R, Al-Awar R, Benovic JL. G protein-coupled receptor kinase 6 (GRK6) regulates insulin processing and secretion via effects on proinsulin conversion to insulin. J Biol Chem 2022;:102421. [PMID: 36030052 DOI: 10.1016/j.jbc.2022.102421] [Reference Citation Analysis]
2 Zhai R, Snyder J, Montgomery S, Sato PY. Double life: How GRK2 and β-arrestin signaling participate in diseases. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110333] [Reference Citation Analysis]
3 Abd Alla J, Quitterer U. The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart. Cells 2022;11:654. [PMID: 35203304 DOI: 10.3390/cells11040654] [Reference Citation Analysis]
4 Yau B, Hocking S, Andrikopoulos S, Kebede MA. Targeting the insulin granule for modulation of insulin exocytosis. Biochem Pharmacol 2021;194:114821. [PMID: 34748819 DOI: 10.1016/j.bcp.2021.114821] [Reference Citation Analysis]
5 Zhang W, Zhang F, Hu Q, Xiao X, Ou L, Chen Y, Luo S, Cheng Y, Jiang Y, Ma X, Zhao Y. The emerging possibility of the use of geniposide in the treatment of cerebral diseases: a review. Chin Med 2021;16:86. [PMID: 34454545 DOI: 10.1186/s13020-021-00486-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Lee SP, Qi J, Xu G, Rankin MM, Littrell J, Xu JZ, Bakaj I, Pocai A. GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action. Front Endocrinol (Lausanne) 2021;12:652628. [PMID: 34054727 DOI: 10.3389/fendo.2021.652628] [Reference Citation Analysis]